Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent-Reference-Cited by-同舟云学术

Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent

Published:2014-02-10 Issue:8 Volume:111 Page:3182-3187
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

King A. L.,Polhemus D. J.,Bhushan S.,Otsuka H.,Kondo K.,Nicholson C. K.,Bradley J. M.,Islam K. N.,Calvert J. W.,Tao Y.-X.,Dugas T. R.,Kelley E. E.,Elrod J. W.,Huang P. L.,Wang R.,Lefer D. J.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference48 articles.

1. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener

2. Hydrogen sulphide and its therapeutic potential

3. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)

4. Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed

5. H 2 S Protects Against Pressure Overload–Induced Heart Failure via Upregulation of Endothelial Nitric Oxide Synthase

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrogen sulfide and its potential as a possible therapeutic agent in male reproduction;Frontiers in Endocrinology;2024-09-11

2. Oxidative stress and vascular dysfunction: Potential therapeutic targets and therapies in peripheral artery disease;Microvascular Research;2024-09

3. Adjunctive therapy with an oral H₂S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction;British Journal of Pharmacology;2024-07-09

4. Sulfur metabolism as a new therapeutic target of heart failure;Journal of Pharmacological Sciences;2024-07

5. Therapeutic Potential of Hydrogen Sulfide in Ischemia and Reperfusion Injury;Biomolecules;2024-06-22